Search alternatives:
"10 ng decrease" » "10 nn decrease" (Expand Search), "10 a decrease" (Expand Search), "10 we decrease" (Expand Search), "100 ng decrease" (Expand Search), "10 mg decrease" (Expand Search), "10 nm decrease" (Expand Search)
"50 n decrease" » "50 nn decrease" (Expand Search), "50 a decrease" (Expand Search), "50 _ decreased" (Expand Search), "50 ns decrease" (Expand Search), "50 ng decrease" (Expand Search), "50 μ decrease" (Expand Search)
Showing 1 - 20 results of 27 for search '(("50 n decrease") OR ((("10 ng decrease") OR ("10 _ decrease"))))', query time: 0.49s Refine Results
  1. 1
    Effect of essential oil TTO and LEO coating of MWCNT filters on bacterial removal rates.

    Effect of essential oil TTO and LEO coating of MWCNT filters on bacterial removal rates. by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  2. 2
    Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation - Fig 4

    Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation - Fig 4 by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  3. 3
    Inactivation rate of the LEO-MWCNTs filters to <i>E</i>. <i>coli</i> cells captured on the filters with different incubation time after the filtering step.

    Inactivation rate of the LEO-MWCNTs filters to <i>E</i>. <i>coli</i> cells captured on the filters with different incubation time after the filtering step. by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  4. 4
    Log of <i>E</i>. <i>coli</i> cell numbers in filtrates after filtering through MWCNT filters with different MWCNT loadings.

    Log of <i>E</i>. <i>coli</i> cell numbers in filtrates after filtering through MWCNT filters with different MWCNT loadings. by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  5. 5
    Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation - Fig 2

    Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation - Fig 2 by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  6. 6
    Inactivation rates of <i>E</i>. <i>coli</i> bacteria retained on the surfaces of LEO-MWCNTs, TTO-MWCNTs, or Mix-MWCNTs filters with 10, 20 or 50 μL EO coatings.

    Inactivation rates of <i>E</i>. <i>coli</i> bacteria retained on the surfaces of LEO-MWCNTs, TTO-MWCNTs, or Mix-MWCNTs filters with 10, 20 or 50 μL EO coatings. by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  7. 7
    The percentage of NaCl tolerant <i>E</i>. <i>coli</i> cells retained on filters.

    The percentage of NaCl tolerant <i>E</i>. <i>coli</i> cells retained on filters. by Xiuli Dong (658906)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  8. 8
    LAM concentration in NTM culture solutions determined by LAM-ELISA.

    LAM concentration in NTM culture solutions determined by LAM-ELISA. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  9. 9
    Study 1 patient enrollment scheme and sputum specimen microbiological characteristics.

    Study 1 patient enrollment scheme and sputum specimen microbiological characteristics. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  10. 10
    Antibodies used in the LAM-ELISA and their epitope specificities.

    Antibodies used in the LAM-ELISA and their epitope specificities. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  11. 11
    Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts

    Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  12. 12
    Sensitivity and specificity of the LAM-ELISA in Study 1.

    Sensitivity and specificity of the LAM-ELISA in Study 1. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  13. 13
    Changes of LAM concentration and MGIT TTD during the 14-day treatment in Study 2.

    Changes of LAM concentration and MGIT TTD during the 14-day treatment in Study 2. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  14. 14
    Baseline patient characteristics for Study 1 and Study 2.

    Baseline patient characteristics for Study 1 and Study 2. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  15. 15
    Correlation of LAM concentration with smear score or MGIT TTD in Study 1.

    Correlation of LAM concentration with smear score or MGIT TTD in Study 1. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  16. 16
    Number of positive cases by each test during treatment among sputum specimens with MGIT data in Study 2.

    Number of positive cases by each test during treatment among sputum specimens with MGIT data in Study 2. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  17. 17
    Number of positive cases by LAM-ELISA and MGIT culture on days 28 and 56 in Study 2.

    Number of positive cases by LAM-ELISA and MGIT culture on days 28 and 56 in Study 2. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  18. 18
    Correlation of LAM concentration and CFU counts in MTB H37Rv.

    Correlation of LAM concentration and CFU counts in MTB H37Rv. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  19. 19
    Correlation of LAM concentration and MGIT TTD at baseline, day 7, day 14, and day 28 in Study 2.

    Correlation of LAM concentration and MGIT TTD at baseline, day 7, day 14, and day 28 in Study 2. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  20. 20
    Study 2 patient enrollment scheme and LAM and MGIT results on sputum specimens collected during the 56-day treatment.

    Study 2 patient enrollment scheme and LAM and MGIT results on sputum specimens collected during the 56-day treatment. by Masanori Kawasaki (274320)

    Published 2019
    Subjects:
    Save to List
    Saved in:

Search Tools: